GeneralNewsBrief

Telix Pharmaceuticals Completes Enrollment in BiPASS Study for Prostate Cancer Imaging

Applied Radiologyvia Google NewsSep 3

Telix Pharmaceuticals Completes Enrollment in BiPASS Study for Prostate Cancer Imaging

Read the source

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.